Cargando…
Immunochemotherapy or chemotherapy alone in primary central nervous system lymphoma: a National Cancer Database analysis
Debate remains over the role of rituximab, a large molecule with reduced central nervous system (CNS) penetration, in therapy for primary CNS lymphoma (PCNSL). Since 2013, the National Cancer Database has distinguished between chemotherapy and immunotherapy for frontline treatment. In this setting,...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515309/ https://www.ncbi.nlm.nih.gov/pubmed/37459209 http://dx.doi.org/10.1182/bloodadvances.2023010352 |